Production (Stage)
Rakovina Therapeutics Inc.
RKV.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.96M | -2.43M | -2.17M | -2.02M | -1.94M |
| Total Depreciation and Amortization | 392.40K | 395.20K | 396.80K | 398.60K | 397.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 168.10K | 167.00K | 170.00K | 151.10K | 141.30K |
| Change in Net Operating Assets | -392.50K | 56.80K | 518.90K | 109.80K | 15.80K |
| Cash from Operations | -2.79M | -1.81M | -1.09M | -1.36M | -1.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 1.51M | 1.51M |
| Total Debt Repaid | -- | -- | 112.80K | 0.00 | 0.00 |
| Issuance of Common Stock | 4.92M | 2.00M | 1.70M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -188.40K | -80.80K | -158.80K | -112.80K | -112.80K |
| Cash from Financing | 3.41M | 1.40M | 1.21M | 1.04M | 1.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 617.60K | -415.10K | 119.60K | -316.60K | -338.20K |